304 related articles for article (PubMed ID: 25509368)
1. Anti glutamate-decarboxylase antibodies: a liaison between localisation related epilepsy, stiff-person syndrome and type-1 diabetes mellitus.
Szűcs A; Barcs G; Winkler G; Soós Z; Folyovich A; Kelemen A; Várallyay P; Kamondi A
Ideggyogy Sz; 2014 Jul; 67(7-8):269-71. PubMed ID: 25509368
[TBL] [Abstract][Full Text] [Related]
2. Radioimmunoassay for glutamic acid decarboxylase (GAD65) autoantibodies as a diagnostic aid for stiff-man syndrome and a correlate of susceptibility to type 1 diabetes mellitus.
Walikonis JE; Lennon VA
Mayo Clin Proc; 1998 Dec; 73(12):1161-6. PubMed ID: 9868413
[TBL] [Abstract][Full Text] [Related]
3. Of stiff men and sweet mice: GAD and diabetes.
Lancet; 1991 Dec; 338(8780):1428-9. PubMed ID: 1683426
[No Abstract] [Full Text] [Related]
4. Stiff-person syndrome associated with cerebellar ataxia and high glutamic acid decarboxylase antibody titer.
Kono S; Miyajima H; Sugimoto M; Suzuki Y; Takahashi Y; Hishida A
Intern Med; 2001 Sep; 40(9):968-71. PubMed ID: 11579968
[TBL] [Abstract][Full Text] [Related]
5. Spectrum of neurological syndromes associated with glutamic acid decarboxylase antibodies: diagnostic clues for this association.
Saiz A; Blanco Y; Sabater L; González F; Bataller L; Casamitjana R; Ramió-Torrentà L; Graus F
Brain; 2008 Oct; 131(Pt 10):2553-63. PubMed ID: 18687732
[TBL] [Abstract][Full Text] [Related]
6. Stiff-person syndrome (SPS) and anti-GAD-related CNS degenerations: protean additions to the autoimmune central neuropathies.
Ali F; Rowley M; Jayakrishnan B; Teuber S; Gershwin ME; Mackay IR
J Autoimmun; 2011 Sep; 37(2):79-87. PubMed ID: 21680149
[TBL] [Abstract][Full Text] [Related]
7. Autoimmunity to glutamic acid decarboxylase (GAD) in Stiff-Man syndrome and insulin-dependent diabetes mellitus.
Solimena M; De Camilli P
Trends Neurosci; 1991 Oct; 14(10):452-7. PubMed ID: 1722364
[TBL] [Abstract][Full Text] [Related]
8. [Stiff-person syndrome and other neurological disorders associated with anti-GAD antibodies].
Hijazi J; Bedat-Millet AL; Hannequin D
Rev Med Interne; 2010 Jan; 31(1):23-8. PubMed ID: 19828214
[TBL] [Abstract][Full Text] [Related]
9. The $64000 question in diabetes continues.
Atkinson MA
Lancet; 2000 Jul; 356(9223):4-6. PubMed ID: 10892753
[No Abstract] [Full Text] [Related]
10. Anti-glutamic acid decarboxylase antibodies in the serum and cerebrospinal fluid of patients with stiff-person syndrome: correlation with clinical severity.
Rakocevic G; Raju R; Dalakas MC
Arch Neurol; 2004 Jun; 61(6):902-4. PubMed ID: 15210528
[TBL] [Abstract][Full Text] [Related]
11. Glutamic acid decarboxylase autoantibodies and neurological disorders.
Vianello M; Tavolato B; Giometto B
Neurol Sci; 2002 Oct; 23(4):145-51. PubMed ID: 12536283
[TBL] [Abstract][Full Text] [Related]
12. Heterogeneity in the occurrence of a subset of autoantibodies to glutamic acid decarboxylase in autoimmune polyendocrine patients with islet cell antibodies.
Davenport C; Radford PM; Al-Bukhari TA; Lai M; Bottazzo GF; Todd I
Clin Exp Immunol; 1998 Mar; 111(3):497-505. PubMed ID: 9528889
[TBL] [Abstract][Full Text] [Related]
13. Humoral autoimmune responses to glutamic acid decarboxylase have similar target epitopes and subclass that show titer-dependent disease association.
Piquer S; Belloni C; Lampasona V; Bazzigaluppi E; Vianello M; Giometto B; Bosi E; Bottazzo GF; Bonifacio E
Clin Immunol; 2005 Oct; 117(1):31-5. PubMed ID: 16027042
[TBL] [Abstract][Full Text] [Related]
14. Glutamic acid decarboxylase autoantibodies in stiff-man syndrome and insulin-dependent diabetes mellitus exhibit similarities and differences in epitope recognition.
Daw K; Ujihara N; Atkinson M; Powers AC
J Immunol; 1996 Jan; 156(2):818-25. PubMed ID: 8543838
[TBL] [Abstract][Full Text] [Related]
15. Stiff Person syndrome and other anti-GAD-associated neurologic disorders.
Dayalu P; Teener JW
Semin Neurol; 2012 Nov; 32(5):544-9. PubMed ID: 23677666
[TBL] [Abstract][Full Text] [Related]
16. Murine monoclonal glutamic acid decarboxylase (GAD)65 antibodies recognize autoimmune-associated GAD epitope regions targeted in patients with type 1 diabetes mellitus and stiff-man syndrome.
Ziegler B; Schlosser M; Lühder F; Strebelow M; Augstein P; Northemann W; Powers AC; Ziegler M
Acta Diabetol; 1996 Sep; 33(3):225-31. PubMed ID: 8904930
[TBL] [Abstract][Full Text] [Related]
17. Anti-GAD positive stiff-person syndrome and cerebellar ataxia: two treatable conditions that clinicians should be aware of.
Ferraz HB
Arq Neuropsiquiatr; 2012 Sep; 70(9):655-6. PubMed ID: 22990718
[No Abstract] [Full Text] [Related]
18. [Stiff person syndrome--case report].
Tomczykiewicz K; Pastuszak Z; Staszewski J; Stepień A
Pol Merkur Lekarski; 2014 Jan; 36(211):28-30. PubMed ID: 24645574
[TBL] [Abstract][Full Text] [Related]
19. GAD65 autoantibody characteristics in patients with co-occurring type 1 diabetes and epilepsy may help identify underlying epilepsy etiologies.
Liimatainen S; Honnorat J; Pittock SJ; McKeon A; Manto M; Radtke JR; ; Hampe CS
Orphanet J Rare Dis; 2018 Apr; 13(1):55. PubMed ID: 29636076
[TBL] [Abstract][Full Text] [Related]
20. Immune reactivity to glutamic acid decarboxylase 65 in stiffman syndrome and type 1 diabetes mellitus.
Lohmann T; Hawa M; Leslie RD; Lane R; Picard J; Londei M
Lancet; 2000 Jul; 356(9223):31-5. PubMed ID: 10892762
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
